XML 25 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Stock-based Compensation
6 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
10.
  STOCK-BASED COMPENSATION
 
The Company’s equity awards consist of RSUs and SARs. For a description of the Company’s stock-based compensation plans, see Note
5
“Stock-Based Compensation” in Notes to Consolidated Financial Statements included in the Annual Report on Form
10
-K for the year ended
January 31, 2017.
 
Stock-Based Compensation
 
The following table sets forth reported stock-based compensation expense for the
three
and 
six
months ended
July 31, 2017
and
2016:
 
 
 
Three Months Ended
July 31,
 
 
Six Months Ended
July 31,
 
 
 
201
7
 
 
201
6
 
 
201
7
 
 
201
6
 
 
 
(in thousands)
 
 
(in thousands)
 
Cost of subscription
  $
36
    $
27
    $
61
    $
49
 
Cost of maintenance and other revenue
   
95
     
73
     
172
     
140
 
Cost of professional services
   
274
     
212
     
494
     
385
 
Sales and marketing
   
368
     
321
     
685
     
598
 
Research and development
   
304
     
249
     
557
     
486
 
General and administrative
   
1,515
     
1,211
     
2,391
     
2,043
 
Total stock-based compensation expense
  $
2,592
    $
2,093
    $
4,360
    $
3,701
 
 
 
RSU Information
 
The estimated fair value of RSUs was calculated based on the closing price of the Company’s common stock on the date of grant, reduced by the present value of dividends foregone during the vesting period.
 
The following table summarizes the activity for RSUs for the
six
months ended
July 31, 2017:
 
 
 
RSUs
   
Weighted
Average
Grant Date
Fair Value
 
 
 
(in thousands)
 
 
 
 
 
                 
Outstanding at January 31, 2017
   
623
    $
20.56
 
Granted
   
293
     
30.66
 
Released
(1)
   
(235
)
   
20.48
 
Forfeited
   
(8
)
   
20.17
 
Outstanding at July 31, 2017
   
673
    $
24.98
 
_________________________
 
(
1
)
The number of RSUs released includes shares withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements.
 
The Company withholds a portion of the released shares as consideration for the Company’s payment of applicable employee income taxes. During the
three
months ended
July 31, 2017,
the Company withheld
70,000
shares for payment of these taxes at a value of
$2.2
million. During the
six
months ended
July 31, 2017,
the Company withheld
72,000
shares for payment of these taxes at a value of
$2.3
million.
  
Total unrecognized compensation cost related to RSUs was approximately
$15.8
million as of
July 31, 2017.
This cost is expected to be recognized over a weighted-average period of approximately
3.1
years. 
 
SAR Information
 
The weighted average assumptions used to value SARs granted in the
six
months ended
July 31, 2017
and
2016
are shown in the following table:
 
 
 
 
 
Six
Months Ended
July
31
,
 
 
 
201
7
 
 
201
6
 
Expected life in years
(1)
   
5.50
     
5.25
 
Risk free interest rate
(2)
   
1.82
%
   
1.16
%
Volatility
(3)
   
33
%
   
36
%
Dividend rate
(4)
   
0.91
%
   
1.51
%
 
____________________________
(
1
)
The expected life of SARs granted under the stock-based compensation plans is based on historical vested SAR exercise and post-vest forfeiture patterns and includes an estimate of the expected term for SARs that were fully vested and outstanding.
 
(
2
)
The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of SARs in effect at the time of grant.
 
(
3
)
The Company estimates the volatility of its common stock at the date of grant based on the historical volatility of the Company’s common stock for a period equivalent to the expected life of the SARs, which it believes is representative of the expected volatility over the expected life of the SARs.
 
(
4
)
The Company expects to continue paying quarterly dividends at the same rate as the
six
months ending on
July 31, 2017.
 
The following table summarizes the activity for outstanding SARs for the
six
months ended
July 31, 2017:
 
 
 
SARs
(in thousands)
 
 
Weighted
Average
Exercise
Price per
Share
 
 
Weighted
Average
Remaining
Contractual
Term (years)
 
 
Aggregate
Intrinsic
Value
(in thousands)
 
Outstanding at January 31, 2017
   
2,793
    $
15.51
     
 
     
 
 
Granted
   
380
     
31.65
     
 
     
 
 
Exercised
   
(73
)
   
10.70
     
 
     
 
 
Expired
   
(1
)
   
9.09
     
 
     
 
 
Forfeited
   
     
     
 
     
 
 
Outstanding at
July 31, 2017
   
3,099
    $
17.60
     
4.4
    $
40,378
 
Vested and exercisable at
July 31, 2017
   
2,146
    $
14.11
     
3.3
    $
35,187
 
 
The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the aggregate difference between the closing stock price of the Company’s common stock based on the last trading day as of
July 31, 2017,
and the exercise price for in-the-money SARs) that would have been received by the holders if all SARs had been exercised on
July 31, 2017.
The total intrinsic value of SARs exercised in the
six
months ended
July 31, 2017
was
$1.4
million. The weighted average grant date fair value per share of SARs granted in the
three
and
six
months ended
July 31, 2017
was
$9.59.
The weighted average grant date fair value per share of SARs granted in the
three
and
six
months ended
July 31, 2016
was
$5.43.
 
The number of SARs exercised includes shares withheld on behalf of employees to satisfy minimum statutory tax withholding requirements.  During the
three
months ended
July 31, 2017,
the Company withheld
12,000
shares for payment of these taxes at a value of
$0.4
million. During the
six
months ended
July 31, 2017,
the Company withheld
16,000
shares for payment of these taxes at a value of
$0.5
million.
 
At
July 31, 2017,
there was approximately
$7.2
million of total unrecognized compensation cost related to unvested SARs. This cost is expected to be recognized over a weighted-average period of approximately
3.0
years.